Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine-Reference-Cited by-同舟云学术

Immunogenicity of a 2-Dose Priming and Booster Vaccination With the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine

Published:2009-10 Issue:10 Volume:28 Page:e276-e282
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Silfverdal Sven Arne,Hogh Birthe,Bergsaker Marianne Riise,Skerlikova Helena,Lommel Patricia,Borys Dorota,Schuerman Lode

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference40 articles.

1. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children.;Black;Pediatr Infect Dis J,2000

2. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.;O'Brien;Lancet,2003

3. Efficacy of a pneumococcal conjugate vaccine against acute otitis media.;Eskola;N Engl J Med,2001

4. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children.;Kilpi;Clin Infect Dis,2003

5. Distribution of protein D, an immunoglobulin D-binding protein, in Haemophilus strains.;Akkoyunlu;Infect Immun,1991

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and vaccine-serotype carriage prevalence after full or fractional doses of Pneumococcal Conjugate Vaccines in Kenyan infants: an individually randomised, controlled, non-inferiority trial;2024-01-24

2. Ribosome display of N-linked glycoproteins in cell-free extracts;2022-06-09

3. Does the change in the immunization dosing schedule of 10-valent pneumococcal conjugate vaccine has any impact among children in the northwest of Sao Paulo, Brazil?;Vacunas (English Edition);2022-05

4. Does the change in the immunization dosing schedule of 10-valent pneumococcal conjugate vaccine has any impact among children in the northwest of Sao Paulo, Brazil?;Vacunas;2022-05

5. Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial;Vaccine: X;2021-04